Literature DB >> 21206138

A case of myxedema coma caused by isolated thyrotropin stimulating hormone deficiency and Hashimoto's thyroiditis.

Keiji Iida1, Yasuhisa Hino, Takeshi Ohara, Kazuo Chihara.   

Abstract

Myxedema coma (MC) is a rare, but often fatal endocrine emergency. The majority of cases that occur in elderly women with long-standing primary hypothyroidism are caused by particular triggers. Conversely, MC of central origin is extremely rare. Here, we report a case of MC with both central and primary origins. A 56-year-old woman was transferred to our hospital due to loss of consciousness; a chest x-ray demonstrated severe cardiomegaly. Low body temperature, bradycardia, and pericardial effusion suggested the presence of hypothyroidism. Endocrinological examination revealed undetectable levels of serum free thyroxine (T(4)) and free triiodothyronine (T(3)), whereas serum thyroid-stimulating hormone (TSH) levels were not elevated. The woman's serum anti-thyroid peroxidase antibody and anti-thyroglobulin antibody tests were positive, indicating that she had Hashimoto's thyroiditis. Provocative tests to the anterior pituitary revealed that she had TSH and growth hormone (GH) deficiency; however, GH levels were restored after supplementation with levothyroxine for 5 months. This was not only a rare case of MC with TSH deficiency and Hashimoto's thyroiditis; the patient also developed severe osteoporosis and possessed transient elevated levels of serum carcinoembryonic antigen (CEA). This atypical case may suggest the role of anterior pituitary hormone deficiencies, as well as hypothyroidism, in the regulation of bone metabolism.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21206138     DOI: 10.1507/endocrj.k10e-329

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  6 in total

Review 1.  Interactions between hypothalamic pituitary thyroid axis and other pituitary dysfunctions.

Authors:  Ulla Feldt-Rasmussen; Marianne Klose; Salvatore Benvenga
Journal:  Endocrine       Date:  2018-09-06       Impact factor: 3.633

2.  Thyroid-stimulating hormone induces a Wnt-dependent, feed-forward loop for osteoblastogenesis in embryonic stem cell cultures.

Authors:  Ramkumarie Baliram; Rauf Latif; Joshua Berkowitz; Simon Frid; Graziana Colaianni; Li Sun; Mone Zaidi; Terry F Davies
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-12       Impact factor: 11.205

3.  Regulation of insulin-like growth factors and their binding proteins by thyroid stimulating hormone in human osteoblast-like (SaOS2) cells.

Authors:  G Ramajayam; R C Vignesh; S Karthikeyan; K Senthil Kumar; G D Karthikeyan; S Veni; M Sridhar; J Arunakaran; M Michael Aruldhas; N Srinivasan
Journal:  Mol Cell Biochem       Date:  2012-06-07       Impact factor: 3.396

4.  Familial longevity is associated with lower baseline bone turnover but not differences in bone turnover in response to rhTSH.

Authors:  Ana Zutinic; Ferdinand Roelfsema; Hanno Pijl; Bart E Ballieux; Rudi G J Westendorp; Gerard J Blauw; Diana van Heemst
Journal:  Aging (Albany NY)       Date:  2021-09-07       Impact factor: 5.682

5.  Myxedema Coma Associated with Macroprolactinoma: Case Report and Review of the Literature.

Authors:  Elizabeth Jasola Omoniyi; Richard J Robbins
Journal:  Case Rep Endocrinol       Date:  2022-04-28

Review 6.  Thyrotropin, Hyperthyroidism, and Bone Mass.

Authors:  Se-Min Kim; Vitaly Ryu; Sari Miyashita; Funda Korkmaz; Daria Lizneva; Sakshi Gera; Rauf Latif; Terry F Davies; Jameel Iqbal; Tony Yuen; Mone Zaidi
Journal:  J Clin Endocrinol Metab       Date:  2021-11-19       Impact factor: 6.134

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.